Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Giorgia Levati"'
Publikováno v:
Drugs. 79:1305-1319
Eltrombopag is an orally available thrombopoietin receptor agonist indicated for the treatment of immune thrombocytopenia (ITP). Beyond the effect on megakaryopoiesis, the drug also showed a stimulating effect on the hematopoietic stem cell with cons
Autor:
S. Lonati, Viviana Beatrice Valli, Giorgia Levati, Daniele Cattaneo, Cristina Bucelli, Umberto Gianelli, Alessandra Iurlo
Publikováno v:
Chemotherapy. 63:340-344
Here, we report the case of a young female affected by primary myelofibrosis (PMF) who developed an osteolytic lesion of the humerus during the follow-up, and the possible efficacy of ruxolitinib in controlling this rare event. After 26 years of foll
Autor:
Benedetta Viani, Daniele Cattaneo, Luca Baldini, Alessandra Iurlo, Maria Domenica Cappellini, Dario Consonni, Dario Tavazzi, Giorgia Levati, Cristina Bucelli
Publikováno v:
American Journal of Hematology. 94
Autor:
Agostino Cortelezzi, Paolo Bucciarelli, Giorgia Levati, Gianluigi Reda, Bruno Fattizzo, Flora Peyvandi, Anna Lecchi, Ramona Cassin, Andrea Artoni, Silvia La Marca
Publikováno v:
British journal of haematology. 183(5)
Autor:
Daniele Fanoni, Emilio Berti, Federica Irene Grifoni, E. Tagliaferri, Giorgia Levati, Agostino Cortelezzi, Nicola Orofino, Francesco Onida, Silvia Alberti Violetti, Giorgia Saporiti, Mariarita Sciumè
Publikováno v:
Blood. 132:4655-4655
Introduction: Although a few novel drugs have recently shown promising activity in mycosis fungoides (MF) and Sézary syndrome (SS), prognosis of patients with advanced stages or refractory disease remain poor, with median survival ranging from 1.4 t
Autor:
Giorgia Levati, Matteo Carrabba, Chiara Bonini, Luca Vago, Fabio Giglio, Fabio Ciceri, Lara Crucitti, Francesca Lorentino, Andrea Assanelli, Laura Bellio, Raffaella Milani, Sarah Marktel, Massimo Bernardi, Maria Teresa Lupo Stanghellini, Consuelo Corti, Raffaella Greco, Tiago De Freitas, Nicoletta Cieri, Jacopo Peccatori, Mara Morelli
Haploidentical hematopoietic stem cell transplantation (HSCT) performed using bone marrow (BM) grafts and post-transplantation cyclophosphamide (PTCy) has gained much interest for the excellent toxicity profile after both reduced-intensity and myeloa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8261628f386cd2a5c44899b28e81dc86
Autor:
Consuelo Corti, Giorgia Levati, Alberto Mantovani, Maria Teresa Lupo Stanghellini, Elisa Sala, Michela Tassara, Fabio Giglio, Francesca Lorentino, Jacopo Peccatori, Roberto Leone, Mara Morelli, Matteo Carrabba, Fabio Ciceri, Raffaella Greco, Barbara Bottazzi, Cecilia Garlanda, Andrea Assanelli, Lara Crucitti, Massimo Bernardi, Luca Vago
Publikováno v:
Blood. 128:4600-4600
BACKGROUND: Pentraxin 3 (PTX3) is an essential component of the humoral arm of innate immunity, involved in controlling infections and modulating inflammation, and acting as a new prognostic and diagnostic biomarker in these conditions. PTX3 has been
Autor:
Maria Teresa Lupo Stanghellini, Raffaella Greco, Consuelo Corti, Roee Dvir, Andrea Assanelli, Maddalena Noviello, Sarah Marktel, Jacopo Peccatori, Matteo Carrabba, Fabio Giglio, Sara Racca, Alessandra Forcina, Veronica Valtolina, Lara Crucitti, Francesca Lorentino, Massimo Clementi, Mara Morelli, Massimo Bernardi, Luca Vago, Serena Rolla, Fabio Ciceri, Chiara Bonini, Giorgia Levati
Publikováno v:
Blood. 124:3899-3899
BACKGROUND: Human herpesvirus type 6 (HHV-6) is increasingly recognized as an opportunistic and potentially life-threatening pathogen in recipients of allogeneic hematopoietic stem cell transplantation (AlloSCT). HHV-6 is a member of the beta herpesv
Autor:
Tiago De Freitas, Mara Morelli, Giorgia Levati, Maria Teresa Lupo Stanghellini, Raffaella Greco, Lara Crucitti, Nicoletta Cieri, Chiara Bonini, Consuelo Corti, Francesca Lorentino, Massimo Bernardi, Fabio Ciceri, Andrea Assanelli, Luca Vago, Jacopo Peccatori, Sarah Marktel, Fabio Giglio
Publikováno v:
Blood. 124:2584-2584
Introduction:Haploidentical hematopoietic stem cell transplantation (HSCT) performed using T–replete BM grafts and post-transplantation cyclophosphamide (PT-Cy) has gained much interest in the transplantation community for the excellent toxicity pr
Autor:
Fabio Ciceri, Sarah Marktel, Simona Piemontese, Fabio Giglio, Consuelo Corti, Chiara Bonini, Andrea Assanelli, Lara Crucitti, Corrado Zuanelli Brambilla, Jacopo Peccatori, Carlo Messina, Mara Morelli, Massimo Bernardi, Luca Vago, Giorgia Levati, Maria Teresa Lupo Stanghellini, Raffaella Greco, Magda Marcatti, Francesca Lorentino, Alessandra Forcina
Publikováno v:
Blood. 122:2149-2149
Background Hematopoietic stem cell transplantation (HSCT) is so far the only potentially curative option for patients with aggressive hematological malignancies. Since many patients cannot find a suitable HLA-identical (related or unrelated) donor, i